Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu

Nutrimedy is a digital health pioneer focused on the next generation of evidence-based clinical nutrition therapy to support patients with conditions that require complex dietary modifications. Nutrimedy&#39;s proprietary solution provides more meaningful, longitudinal support through built-in video appointments, scheduling, provider matching algorithm, secure messaging, file sharing, educational content, customizable trackers, and condition specific AI photo food logging. The Nutrimedy platform also enables the collection of dietary intake data within clinical and research settings. By using image recognition to validate nutrient intake and seamlessly share the data with the research team, Nutrimedy removes the need for resource intensive nutrient data gathering methods. As a B2B company, Nutrimedy supports pharmaceutical and medical device partners by providing a digital therapeutic companion specifically designed for conditions that include cancer, IBD, and heart failure.

Nutrimedy - HLTH 2021 Sponsor

NTT DATA Services is a recognized leader in IT and business services including cloud, data and applications. <br><br>A division of NTT DATA headquartered in Texas, the company leverages consulting and deep industry expertise to help clients accelerate and sustain value throughout their digital journeys. With over 50 years of healthcare experience and an overall R&amp;D investment of $3.6 billion, we work with clients to create efficiencies that improve health and wellbeing.

NTT DATA - HLTH 2021 Sponsor

Nucleai is a precision medicine company that has developed an AI-powered pathology-based biomarker discovery platform to unlock the power of spatial biology from pathology images. Our platform, built and trained off large-scale proprietary datasets, leverages computer vision and deep neural networks to structure and characterize tissue and cell architecture in pathology images to identify spatial characteristics that predict response to therapy and inform treatment decision. Our vision is for every pathology image to run through the Nucleai platform, starting with pharma to augment biomarker discovery and development and eventually as FDA-approved diagnostics tools in the hands of physicians.

Nucleai - HLTH 2021 Sponsor